[Research on human ovarian cancer cell MDR1 gene silenced by siRNA]

Jiang-yan Lou1, Zhi-lan Peng, Ying Zheng

  • 1Department of Obsterics and Gynecology, West China Second Hospital, Sichuan University, Chengdu 610041, China.

Abstract

Insights

Small interfering RNA (siRNA) effectively inhibits multidrug resistance gene 1 (MDR1) mRNA and P-glycoprotein (P-gp) expression in ovarian cancer cells. This RNA interference approach shows promise for overcoming drug resistance in cancer treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Multidrug resistance (MDR) is a significant challenge in ovarian cancer treatment.
  • The multidrug resistance gene 1 (MDR1) and its product P-glycoprotein (P-gp) are key mediators of MDR.
  • Targeting MDR1 expression offers a potential strategy to overcome drug resistance.

Purpose of the Study:

  • To evaluate the efficacy of small interfering RNA (siRNA) in inhibiting MDR1 mRNA and P-gp expression.
  • To assess the impact of siRNA on multidrug resistance in an ovarian cancer cell line.

Main Methods:

  • Ovarian cancer cell line OVCAR8/TR was transfected with siRNA.
  • Real-time RT-PCR was used to quantify MDR1 mRNA expression.
  • Flow cytometry was employed to determine P-gp expression levels.

Main Results:

  • siRNA transfection resulted in significant inhibition of MDR1 mRNA (84% at 48 hours) and P-gp (85.23% at 72 hours) expression.
  • Inhibited expression levels gradually returned to normal over time.
  • No significant difference in expression was observed between negative control and untransfected cells.

Conclusions:

  • RNA interference using siRNA effectively suppresses MDR1 mRNA and P-gp expression in human ovarian cancer cells.
  • This RNA interference strategy presents a potential new therapeutic approach for MDR1-mediated drug resistance in ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...